Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

All articles by Andrea S. Blevins Primeau, PhD, MBA

Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.

News

TVUS ET Screening Misses More Cases of Endometrial Cancer in Black Women Than in White Women

Andrea S. Blevins Primeau, PhD, MBA

July 30, 2021

The disparity is due to the greater prevalence of fibroids and nonendometrioid histologic type in Black women, according to researchers.

Among 4 specific breast cancer stages, T2N1 cancers showed the highest risk for local recurrence, re

News

Long-Term Follow-Up Confirms Utility of MammaPrint to Guide Treatment of Breast Cancer

Andrea S. Blevins Primeau, PhD, MBA

May 31, 2021

Older breast cancer patients with high clinical risk but low genomic risk have “excellent” 8-year distant metastasis-free survival when treated with endocrine therapy alone.

The pitfall of self-reported stress levels is that the baseline stress for some people is so high, a cancer diagnosis doesn’t even register.

Medicine

Globalization of Cancer Clinical Trials Widens Disparity in Black Patient Enrollment

Andrea S. Blevins Primeau, PhD, MBA

May 3, 2021

The median disparity score was 0.19, with a score of 1 indicating no disparity between clinical trial enrollment and burden of disease.

This fact sheet evaluates the data that suggest that aspirin can reduce the risk of liver and ovaria

Medicine

Common Cardiovascular Drugs Associated With Reduced Lung Cancer Mortality

Andrea S. Blevins Primeau, PhD, MBA

September 25, 2020

Aspirin, metformin, and statins were independently associated with decreased lung cancer mortality, according to a population-based study.

Medicine

ASCO Releases Position Statement on Home Infusion of Anticancer Treatments

Andrea S. Blevins Primeau, PhD, MBA

August 17, 2020

ASCO raises concerns about the home infusion of anticancer therapies including patient and caregiver safety, adequate oncology infusion nurses, and reimbursement issues.

Medicine

Lung Cancer Trials Supported by the Pharmaceutical Industry More Likely to Report Strong Evidence, Be Open Access

Andrea S. Blevins Primeau, PhD, MBA

July 30, 2020

A study of clinical trials found no evidence of bias in the reporting of clinical trials supported by pharmaceutical companies compared with studies that had other funding sources.

An FDA pilot program to promote transparency in clinical studies falls short of similar efforts by its European and Canadian counterparts.

Medicine

The Effect of the COVID-19 Pandemic on Telehealth

Andrea S. Blevins Primeau, PhD, MBA

July 24, 2020

Regulations on telehealth services were rapidly deregulated early into the COVID-19 pandemic, but questions remain about quality of care and patient disparities.

This fact sheet describes how artificial intelligence is currently being used in oncology.

Medicine

Artificial Intelligence in Cancer: How Is It Used in Practice?

Andrea S. Blevins Primeau, PhD, MBA

June 22, 2020

This fact sheet describes how artificial intelligence is currently being used in oncology.

Next post in Medicine